Genetic variants within immune-modulating genes influence the risk of developing rheumatoid arthritis and anti-TNF drug response

Copyright © 2015 Wolters Kluwer Health, Inc. All rights reserved.

Bibliographic Details
Main Author: Canet, Luz M. (author)
Other Authors: Cáliz, Rafael (author), Lupiañez, Carmen B. (author), Canhao, Helena (author), Martinez, Manuel (author), Escudero, Alejandro (author), Filipescu, Ileana (author), Segura-Catena, Juana (author), Soto-Pino, María J. (author), Ferrer, Miguel A. (author), García, Antonio (author), Romani, Lurdes (author), Pérez-Pampin, Eva (author), González-Utrilla, Alfonso (author), López Nevot, Miguel Ángel (author), Collantes, Eduardo (author), Fonseca, João Eurico (author), Sainz, Juan (author)
Format: article
Language:eng
Published: 2022
Subjects:
Drug response
Genetic variants
IL4
IL8RB
IFNG
Rheumatoid arthritis
Susceptibility
Online Access:http://hdl.handle.net/10451/50709
Country:Portugal
Oai:oai:repositorio.ul.pt:10451/50709

Internet

http://hdl.handle.net/10451/50709

Similar Items